Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
- Status
- RECRUITING
- Phase
- PHASE2
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE3
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
- Status
- RECRUITING
- Phase
- PHASE2
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2